Salflumix Easyhaler is a combination medication containing two active substances: salmeterol and fluticasone propionate:
The doctor may prescribe this medication to prevent breathing disorders that occur in:
Salflumix Easyhaler should be used daily as recommended by the doctor. This will ensure the proper functioning of the medication to control the symptoms of asthma or COPD.
Salflumix Easyhaler prevents the occurrence of shortness of breath and wheezing.
However, Salflumix Easyhaler should not be used to control sudden attacks of shortness of breath or wheezing. In such a situation, a fast-acting inhalation medication should be used to relieve symptoms, such as salbutamol. A fast-acting inhalation medication should always be carried with you.
Before starting to use Salflumix Easyhaler, the patient should discuss with their doctor if they have:
The patient should inform their doctor if they experience blurred vision or other vision disturbances.
The patient should inform their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take, including other medications used to treat asthma and over-the-counter medications. Salflumix Easyhaler may not be suitable for use with certain other medications.
Before starting to use Salflumix Easyhaler, the patient should inform their doctor if they are taking:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medication.
It is unlikely that Salflumix Easyhaler will affect the ability to drive and operate machinery.
Salflumix Easyhaler contains approximately 17.1 mg of lactose monohydrate as an excipient.
In people with lactose intolerance, this amount of lactose is not usually a problem.
The excipient - lactose contains small amounts of milk protein, which can cause allergic reactions. If the patient has previously been diagnosed with intolerance to certain sugars, they should contact their doctor before taking the medication.
This medication should always be used as recommended by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
If the symptoms of asthma are well-controlled while using Salflumix Easyhaler twice a day, the doctor may recommend reducing the frequency of use to once a day. The dose can be given:
If the patient is using Salflumix Easyhaler for asthma, the doctor will regularly check the patient's symptoms.
There may be an increase in wheezing, more frequent occurrence of chest tightness, or the need to use a higher dose of a fast-acting inhalation medication to relieve symptoms. In such a situation, the patient should continue to use the medication, but not increase the number of inhalations. The symptoms of the disease may worsen, and the patient's condition may deteriorate.
The patient should contact their doctor, as they may need additional treatment.
It is essential to use the inhaler as instructed. If a higher dose than recommended is used by mistake, the patient should inform their doctor or pharmacist. The patient may experience a faster than usual heartbeat and trembling. They may also experience dizziness, headache, muscle weakness, and joint pain.
If the patient has been taking too high doses of Salflumix Easyhaler for an extended period, they should consult their doctor or pharmacist for advice, as taking too high doses of Salflumix Easyhaler may lead to a decrease in the production of steroid hormones by the adrenal glands.
The patient should not take a double dose to make up for a missed dose. They should take the next dose at the usual time.
It is crucial to take Salflumix Easyhaler daily, as recommended by the doctor. The medication should be taken until the doctor recommends stopping the treatment. The patient should not stop using Salflumix Easyhaler or suddenly reduce the dose. This may lead to worsening breathing problems.
Additionally, suddenly stopping or reducing the dose of Salflumix Easyhaler may (very rarely) cause adrenal gland problems (adrenal insufficiency), which can sometimes lead to side effects.
These side effects include:
If the body is under stress, such as due to fever, injury (such as a car accident), infection, or surgery, adrenal insufficiency may worsen, and any of the above side effects may occur.
If the patient experiences any side effects, they should inform their doctor or pharmacist. The doctor may prescribe additional corticosteroids in the form of tablets (e.g., prednisolone) to prevent these symptoms.
In case of any further doubts about using this medication, the patient should consult their doctor, pharmacist, or nurse.
Like all medications, Salflumix Easyhaler can cause side effects, although not everybody gets them.
To minimize the risk of side effects, the doctor will prescribe the smallest dose of Salflumix Easyhaler that controls asthma or COPD.
The patient may experience a very wheezy breath, cough, or shortness of breath. They may also experience itching, rash (hives), and swelling (usually of the face, lips, tongue, and throat) or a very rapid heartbeat or fainting and dizziness (which can lead to loss of consciousness or fainting). If any of the above side effects occur or appear suddenly after using Salflumix Easyhaler, the patient should stop using Salflumix Easyhaler and immediately inform their doctor.Allergic reactions to Salflumix Easyhaler are uncommon (they may occur less often than in 1 in 100 people).
The patient should inform their doctorif they experience any of the following symptoms while using Salflumix Easyhaler, as they may be symptoms of a lung infection:
Other side effects are listed below:
Very common ( may occur more often than in 1 in 10 people):
Common ( may occur less often than in 1 in 10 people):
In patients with chronic obstructive pulmonary disease (COPD), the following common side effects have also been reported:
Uncommon ( may occur less often than in 1 in 100 people):
Rare ( may occur less often than in 1 in 1,000 people):
Unknown ( frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medication.
Salflumix Easyhaler is an inhaler filled with medication. The inhalation powder is white. Each inhaler contains 60 doses and has a white body with a purple upper part.
Salflumix Easyhaler is available in a pack containing 1 inhaler of 60 doses, in protective packaging or without protective packaging, in a carton. If the patient needs protective packaging, they should contact the marketing authorization holder (details below).
Orion Corporation
Orionintie 1
02200 Espoo
Finland
Orion Corporation, Orion Pharma
Orionintie 1
02200 Espoo
Finland
To obtain more detailed information about this medication, the patient should contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Detailed and up-to-date information about the use of this medication is available by scanning the QR code (located on both the outer packaging and the inhaler label) using a smartphone. The same information is available on the website: www.oeh.fi/sfpl
QR code for the website www.oeh.fi/sfpl
The Salflumix Easyhaler inhaler may differ from the inhalers the patient has used in the past. Therefore, it is essential to use it correctly, as incorrect use may result in the patient not receiving the correct amount of medication. This may lead to worsening of the patient's condition or inadequate treatment of asthma or COPD.
The doctor, nurse, or pharmacist will show the patient how to use the inhaler correctly. The patient should make sure they understand how to use the inhaler correctly. In case of doubts, the patient should consult their doctor, nurse, or pharmacist. As with all inhalers, caregivers should ensure that children prescribed Salflumix Easyhaler use the correct inhalation technique, as described below. The patient can also watch a video tutorial at: www.oeh.fi/sfpl
The Easyhaler inhaler is supplied in a laminated pouch. The pouch should not be opened until the patient is ready to start using the medication, as it helps to keep the powder in the inhaler dry. If the patient is ready to start treatment, they should open the pouch and write down the opening date, for example, in a calendar. The Salflumix Easyhaler inhaler can be used for 1 month (in the case of 50 micrograms + 250 micrograms) or 2 months (in the case of 50 micrograms + 500 micrograms) after removal from the pouch. To remember this, the patient should write down the date of opening the pouch. | ![]() |
Step 1: SHAKING
| SHAKE 3 TO 5 TIMES | Important information to remember
|
Step 2: CLICKING
| CLICK 1 TIME![]() | Important information to remember
|
Step 3: INHALATION
| INHALATION | Important information to remember
|
![]() | Do not exhale into the inhaler. This is important: it may block the inhaler. If the patient exhales into the inhaler, they should remove the powder from the mouthpiece, as described below. |
How to remove powder from the mouthpiece In case of accidental clicking of the inhaler or multiple clicking of the inhaler, or exhaling into the inhaler, the powder should be removed from the mouthpiece:
| ![]() |
The inhaler should be kept dry and clean. If necessary, the mouthpiece of the inhaler can be cleaned with a dry cloth or tissue. Do not use water. The powder in the Easyhaler inhaler is sensitive to moisture.
Using the Easyhaler inhaler in protective packaging The Easyhaler inhaler can be used in protective packaging, which may help to increase the product's shelf life. Before placing the inhaler in the protective packaging, ensure that the mouthpiece cover is covering the mouthpiece, which will prevent accidental activation of the inhaler. The inhaler can be used without removing it from the protective packaging. Use as described above, 1. Shaking, 2. Clicking, 3. Inhalation. Remember to:
| ![]() |
Switching to a new Easyhaler inhaler The inhaler has a dose counter that shows the number of doses left. The counter turns every five activations. When the dose counter turns red, it means that there are 20 doses left. If the patient does not have a new Easyhaler inhaler, they should contact their doctor to obtain a new prescription. When the dose counter shows 0, the patient should replace the Easyhaler inhaler. If the patient is using protective packaging, they should keep it and place the new inhaler in it. | ![]() |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.